Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mustaqeem Siddiqui

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
Leukemia & Lymphoma|July 9, 2008
The role of high-dose chemotherapy followed by peripheral blood stem cell transplantation for the treatment of multiple myelomaMustaqeem Siddiqui, Morie Gertz
Mayo Clinic Proceedings|March 16, 2013
In replyMustaqeem Siddiqui, S Vincent Rajkumar
Mayo Clinic Proceedings|October 6, 2012
The high cost of cancer drugs and what we can do about itMustaqeem Siddiqui, S Vincent Rajkumar
Cureus|February 1, 2022
An Uncommon Cause of Acute Encephalopathy in Multiple MyelomaJawaher Al Zeyoudi, Aisha Al Naqbi, Deanne Kashiwagi, et al.
Clinical Transplantation|July 22, 2014
Cost-effectiveness analysis of early vs. late autologous stem cell transplantation in multiple myelomaChintan Pandya, Shahrukh Hashmi, Nandita Khera, et al.
Leukemia Research|September 28, 2015
Prognostic impact of combined NPM1+/FLT3- genotype in patients with acute myeloid leukemia with intermediate risk cytogenetics stratified by age and treatment modalitiesMehrdad Hefazi, Mustaqeem Siddiqui, Mrinal Patnaik, et al.
Acta Haematologica|April 2, 2024
Consensus-Based Expert Recommendations on the Management of Hemophilia A in the Gulf RegionHazzaa Abdulla Alzahrani, Ashraf Warsi, Ali Mullah-Ali, et al.
Blood Cancer Journal|May 7, 2025
The ratio of brain to liver glucose activity and disease activity in multiple myelomaSarah Dingli, Paul Rothweiler, Moritz Binder, et al.
American Journal of Hematology|July 15, 2025
Lymphocyte Kinetics and Outcomes of Chimeric Antigen Receptor T Cell Therapy in Multiple Myeloma With Out of Specification ProductsSarah Dingli, Paul Rothweiler, Moritz Binder, et al.
Leukemia|March 5, 2025
Implications of lymphocyte kinetics after chimeric antigen receptor T cell therapy for multiple myelomaSarah Dingli, Paul Rothweiler, Moritz Binder, et al.
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Leukemia & Lymphoma|July 9, 2008
The role of high-dose chemotherapy followed by peripheral blood stem cell transplantation for the treatment of multiple myelomaMustaqeem Siddiqui, Morie Gertz
Mayo Clinic Proceedings|March 16, 2013
In replyMustaqeem Siddiqui, S Vincent Rajkumar
Mayo Clinic Proceedings|October 6, 2012
The high cost of cancer drugs and what we can do about itMustaqeem Siddiqui, S Vincent Rajkumar
Cureus|February 1, 2022
An Uncommon Cause of Acute Encephalopathy in Multiple MyelomaJawaher Al Zeyoudi, Aisha Al Naqbi, Deanne Kashiwagi, et al.
Clinical Transplantation|July 22, 2014
Cost-effectiveness analysis of early vs. late autologous stem cell transplantation in multiple myelomaChintan Pandya, Shahrukh Hashmi, Nandita Khera, et al.
Leukemia Research|September 28, 2015
Prognostic impact of combined NPM1+/FLT3- genotype in patients with acute myeloid leukemia with intermediate risk cytogenetics stratified by age and treatment modalitiesMehrdad Hefazi, Mustaqeem Siddiqui, Mrinal Patnaik, et al.
Acta Haematologica|April 2, 2024
Consensus-Based Expert Recommendations on the Management of Hemophilia A in the Gulf RegionHazzaa Abdulla Alzahrani, Ashraf Warsi, Ali Mullah-Ali, et al.
Blood Cancer Journal|May 7, 2025
The ratio of brain to liver glucose activity and disease activity in multiple myelomaSarah Dingli, Paul Rothweiler, Moritz Binder, et al.
American Journal of Hematology|July 15, 2025
Lymphocyte Kinetics and Outcomes of Chimeric Antigen Receptor T Cell Therapy in Multiple Myeloma With Out of Specification ProductsSarah Dingli, Paul Rothweiler, Moritz Binder, et al.
Leukemia|March 5, 2025
Implications of lymphocyte kinetics after chimeric antigen receptor T cell therapy for multiple myelomaSarah Dingli, Paul Rothweiler, Moritz Binder, et al.
Pageof 5